Satyendra Kumar Singh

Satyendra Kumar Singh is a Researcher at the Institute for Global Health within the College of Engineering at Michigan State University. His work focuses on biomedical engineering applications in oncology, radiation biology, and toxicology. He investigates targeted therapies including alpha-particle emitters, novel PET imaging agents, and mechanisms of chemical warfare agent-induced skin toxicity. Singh’s research integrates preclinical models to evaluate therapeutic efficacy and disease mechanisms.

Key research areas include: medical imaging probe development, cancer radiotherapy optimization, inflammatory response modulation in toxicological exposures, and parasitic disease pathogenesis. His work spans translational medicine bridging basic science and clinical applications. Recent studies emphasize immune-competent mouse models for evaluating combined radiation/immunotherapy and the role of mast cells in chemical injury pathways.

Publications (2020-2025) reveal a strong focus on: 1) Hepatospecific PET agent design (Cu-64 labeled compounds), 2) Bismuth-212 based targeted radiotherapy for solid tumors, 3) Mechanisms of phosgene oxime-induced skin damage, and 4) RAGE signaling pathways in oncogenesis. Current laboratory work involves developing supersaturated oxygen emulsions for corneal injury treatment and exploring the Lysophosphatidic acid-RAGE axis in tumor progression.

Awards section: No specific honors listed in provided materials. Grant information not explicitly detailed but implied through publication activity.

Labs/Teams: Active in the Institute for Global Health's biomedical engineering research group, collaborating across departments in the College of Engineering and College of Veterinary Medicine (implied through parasitology work).